Clinical and Biological Predictors of COVID-19 Disease in Older Patients
ReportAge-COVID Project: Clinical and Biological Predictors of COVID-19 Disease in Older Patients
1 other identifier
observational
300
1 country
3
Brief Summary
The project is an observational, prospective study. Its aim is to deepen our understanding of COVID-19 in older patients hospitalized and diagnosed with COVID-19. In particular, socioeconomic, diagnostic, biological, functional, therapy data will be collected at the patients' admission, during hospital stay, at the discharge and 1, 3, 6, 12 months after discharge. Results and findings will help support changes in clinical practice and decision making, with the aim to reduce the use of healthcare services and the healthcare expenditure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 3, 2020
CompletedFirst Submitted
Initial submission to the registry
April 10, 2020
CompletedFirst Posted
Study publicly available on registry
April 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedOctober 23, 2023
October 1, 2023
4.1 years
April 10, 2020
October 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Descriptive-epidemiological analysis of health conditions
Collection of a set of data and indicators of the health conditions including personal data, clinical care, biological and diagnostic data, treatments/procedures and drug therapy
Patients will be followed for the duration of hospital stay, an expected average of 20 days
Secondary Outcomes (6)
Evaluation of frailty condition
At admission, at discharge, an expected average of 6 weeks and at 1, 3, 6, 12 months after discharge
Identification of biomarkers of inflammation
At admission, at discharge, an expected average of 6 weeks and at 1, 3, 6, 12 months after discharge
Assessment of functional capacity
At admission, at discharge, an expected average of 6 weeks and at 1, 3, 6, 12 months after discharge
Assessment of functional capacity
At admission, at discharge, an expected average of 6 weeks and at 1, 3, 6, 12 months after discharge
Evaluation of drug consumption
At admission, at discharge, an expected average of 6 weeks and at 1, 3, 6, 12 months after discharge
- +1 more secondary outcomes
Study Arms (1)
Elderly patients affected by COVID-19
The group taken into consideration consists of elderly patients hospitalized with diagnosed COVID-19.
Eligibility Criteria
Elderly patients 65 years old and above hospitalized for COVID-19
You may qualify if:
- diagnosis of COVID-19
You may not qualify if:
- no informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
IRCCS INRCA Hospital
Ancona, 60129, Italy
IRCCS INRCA Hospital
Casatenovo, Italy
IRCCS INRCA Hospital
Fermo, Italy
Related Links
Biospecimen
The surplus of serum and plasma in the blood samples taken from patients for routine examinations during hospitalization will be stored at -80°C at the BioGer biobank of IRCCS INRCA.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2020
First Posted
April 16, 2020
Study Start
April 3, 2020
Primary Completion
April 30, 2024
Study Completion
April 30, 2024
Last Updated
October 23, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share